Evaluation of Leukocyte DNA Damage and Antioxidant Defense in Graves’ Disease; Effect of Medical Treatment
Journal Title: International Journal of Clinical Pharmacology & Toxicology(IJCPT) - Year 2017, Vol 6, Issue 3
Abstract
Background: Oxidative stress has been implicated in many pathological conditions, including hyperthyroidism. In this study, our aim was to investigate the effect of medical treatment on oxidative/antioxidative status and subsequent DNA damage in Graves’ disease, in terms of reduced glutathione (GSH) levels, superoxide dismutase (SOD), glutathione peroxidase (GPx) activity and DNA strand breaks. Methods: Fifty female patients suffering from Graves’ disease and thirty-seven healthy female controls were recruited in the study. Blood samples were taken from the patients before and after treatment. Free T3, free T4 and thyroid stimulating hormone (TSH) levels were determined using chemiluminescent particle assay, GSH, SOD and GPx activity using photometric techniques, and comet assay was utilized to analyze strand breaks with formamidopyrimidine DNA glycosylase (FPG) sensitive sites. Results: Free T3, free T4, GPx activity, DNA strand breaks and FPG sensitive sites were significantly higher, and TSH and GSH levels were significantly lower in patients prior to treatment compared to healthy controls. Following treatment, the levels of free T3, free T4 and TSH were restored to those of healthy controls, but the rise in GSH levels and the drop in GPx activity, strand breaks and FPG sensitive sites were not as profound, though still significantly different than pre treatment levels. Conclusions: The markers of oxidative stress and DNA damage are not restored as quickly as thyroid function tests in Graves’ disease following treatment, suggesting the oxidative damage caused by hyperthyroidism may have long term effects.
Authors and Affiliations
Tulay Akcay
Keywords
Related Articles
- EP ID EP324209
- DOI 10.19070/2167-910X-1700046
- Views 65
- Downloads 0
Effect of Some Anti hypertensive Drugs on Alkaline Phosphatase and DNA of Mice
The dislipidemias are a risk factor well recognized of the cardiovascular diseases and constitute a problem of public health. A descriptive study in 150 patient elders of 30 years with diagnosis of Izquemic Cardiopathyes...
AT2 receptor: Its role in obesity associated hypertension
The renin-angiotensin system (RAS) is a hormonal cascade that acts together to regulate blood pressure. Angiotensin II (Ang II) is the major octapeptide of RAS and mediates its cellular and physiological actions by actin...
A Possible Association of Sex Hormone-Binding Globulin with Weight Gain in the Valproic Acid-Treated Female Patients with Epilepsy
Weight gain is a common adverse consequence of treatment with valproic acid. Although a low sex hormone-binding globulin (SHBG) level was shown to be an independent risk factor for the development of metabolic syndrome a...
PAR-2-Mediated Relaxation of Rectum is Impaired Following Bacillary Dysentery in Rat
Background: PAR-2 activation modifies the intestinal motility and takes part in gastrointestinal motility disturbances under intestinal infection or inflammation, but its role in the regulation of normal rectum motility...
Efficacy of Montelukast and Ranitidine as an Add on Therapy for Chronic Urticaria
Background: Chronic urticaria is a highly distressing disease affecting a person’s quality of life. In most cases, monotherapy fails. Hence, combinations of antihistamines with montelukast, H2 blockers, ciclosporin, daps...